Tassin v. Sears, Roebuck and Co.

946 F. Supp. 1241, 46 Fed. R. Serv. 125, 1996 U.S. Dist. LEXIS 18163, 1996 WL 700785
CourtDistrict Court, M.D. Louisiana
DecidedDecember 5, 1996
DocketCivil Action 93-147
StatusPublished
Cited by23 cases

This text of 946 F. Supp. 1241 (Tassin v. Sears, Roebuck and Co.) is published on Counsel Stack Legal Research, covering District Court, M.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tassin v. Sears, Roebuck and Co., 946 F. Supp. 1241, 46 Fed. R. Serv. 125, 1996 U.S. Dist. LEXIS 18163, 1996 WL 700785 (M.D. La. 1996).

Opinion

ORDER AND REASONS

VANCE, District Judge.

Before the Court is Defendants’ Motion to Exclude the Expert Testimony of Stephen Killingsworth. The Court conducted a Dau-bert hearing on Friday, November 22, 1996. For the reasons stated below, defendants’ motion is granted in part and denied in part.

I. BACKGROUND

This is a product liability case arising out of an injury to the left hand of plaintiff, Henry Tassin. Mr. Tassin sustained the injury in 1992 while using a Craftsman 10-inch table, saw manufactured by defendants, Sears, Roebuck, and Company (“Sears”) and Emerson Electric Company (“Emerson”). Mr. Tassin purchased the saw from Sears in 1989.

Plaintiff seeks recovery under the Louisiana Products Liability Act (“LPLA” or “the Act”), La.R.S. 9:2800.51-9:2800.57, on the theories of defective design and inadequate warning. Mr. Tassin intends to introduce the expert testimony of Stephen Killings-worth on both of these issues, as well as on a claim that there was concerted action by power tool manufacturers to avoid incorporating safety devices into their products.

Defendants now move to exclude Mr. Kill-ingsworth’s testimony on the grounds that his opinions regarding alternative product design are speculative and that his methodology fails to satisfy the scientific rigor required by Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). Additionally, defendants challenge Mr. Killingsworth’s criticism of their product warnings as not properly grounded in the scientific method. Finally, defendants seek to exclude Mr. Killings-worth’s testimony concerning an alleged conspiracy in the power tool industry as irrelevant, not the proper subject of expert testimony, and as more prejudicial than probative.

II. LEGAL STANDARDS

A. The Louisiana Products Liability Act

Section 2800.54(A) of the LPLA provides that a product manufacturer shall be liable to a claimant for damage proximately caused by an unreasonably dangerous characteristic of the product, if such damage arises from a reasonably anticipated use of the product by the claimant. Under the LPLA, a product *1244 cari be unreasonably dangerous: (1) in construction or composition; (2) in design; (3) because an adequate warning about the product has not been provided; or (4) because the product does not conform to an express warranty of the manufacturer. La.R.S. 9:2800.54(B).

Plaintiffs here have asserted that defendants’ table saw was unreasonably dangerous in design and/or due to an inadequate warning. The LPLA establishes the elements of each of these claims.

1. Defective Design

To establish that a product is unreasonably dangerous in design, a claimant must prove the following: (1) that there existed an alternative design for the product that was capable of preventing the claimant’s damage at the time the product left the control of its manufacturer; and (2) that the likelihood that the product’s design would cause the claimant’s damage and the gravity of that damage outweighed the burden on the manufacturer of adopting such alternative design and the adverse effect, if any, of such alternative design on the utility of the product. La.R.S. 9:2800.56. An adequate warning about a product must be considered in evaluating the likelihood of damage when the manufacturer has used reasonable care to provide an adequate warning to users and handlers of the product. Id.

2. Inadequate Warning

To establish that a product is unreasonably dangerous because of an inadequate warning, a claimant must show that at the time the product left the manufacturer’s control, the product possessed a characteristic that could cause damage and that the manufacturer failed to use reasonable care to provide an adequate warning of the danger to users and handlers of the product. La.R.S. 9:2800.57(A). The manufacturer is not required to provide an adequate warning about his product when: (1) the product is not dangerous to an extent beyond that which would be contemplated by the ordinary user or handler of the product, with the ordinary knowledge common to the community; or (2) the user or handler of the product already knows or reasonably should be expected to know of the potential danger of the product. La.R.S. 9:2800.57(B).

B. The Dauberb Decision

In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), the Supreme Court addressed the standard for admitting expert scientific testimony under the Federal Rules of Evidence. It concluded that the Federal Rules of Evidence replaced Frye v. United States, 293 F. 1013, 1014 (1923), which required scientific evidence to be “generally accepted” as reliable in the relevant scientific community before it could be admitted. Under Rule 702 of the Federal Rules of Evidence, a “trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but rehable.” Id. 509 U.S. at 589, 113 S.Ct. at 2795. The Court added that “this entails a preliminary assessment of whether the reasoning or methodology underlying the testimony is scientifically valid and of whether that reasoning or methodology can properly be applied to the facts in issue.” Id. at 592-93, 113 S.Ct. at 2796. The Court held that the proposed testimony must be supported by “appropriate validation — i.e., ‘good grounds,’ based on what is known.” Id. The Court then made some “general observations” as to the factors that may inform the district court’s preliminary assessment, stressing that many factors bear on the inquiry and that it was not setting forth a “definitive checklist.” 509 U.S. at 593, 113 S.Ct. at 2796-97. The Court mentioned the following factors: (1) whether the expert’s hypothesis can be and has been tested; (2) whether the hypothesis has been subjected to peer review or publication; (3) the known or potential rate of error; and (4) whether the theory is generally accepted within the relevant community. Id. at 593-94, 113 S.Ct. at 2796-97. The Dauberb Court stressed that the inquiry is a flexible one focused solely on principles and methodology, not on the conclusion generated. Id. at 594-95, 113 S.Ct. at 2797.

Defendants contend that the Court must systematically apply the Dauberb factors to Mr. Killingsworth’s opinion on alter-

*1245 native designs and inadequate warnings. The Court in

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vallee v. Crown Equipment
Fifth Circuit, 2023
Jimerson v. Lewis
N.D. Texas, 2022
JFJ Toys, Inc. v. Sears Holdings Corp.
237 F. Supp. 3d 311 (D. Maryland, 2017)
Orthoflex, Inc. v. Thermotek, Inc.
986 F. Supp. 2d 776 (N.D. Texas, 2013)
Morris v. State
361 S.W.3d 649 (Court of Criminal Appeals of Texas, 2011)
Morris, Daniel Ray
Court of Criminal Appeals of Texas, 2011
Hoy v. DRM, INC.
2005 WY 76 (Wyoming Supreme Court, 2005)
George v. Housing Authority of New Orleans
906 So. 2d 1282 (Louisiana Court of Appeal, 2005)
General Motors Corp. v. Jernigan
883 So. 2d 646 (Supreme Court of Alabama, 2003)
Downs v. Perstorp Components, Inc.
126 F. Supp. 2d 1090 (E.D. Tennessee, 1999)
Moore v. Ashland Chemical Inc.
151 F.3d 269 (Fifth Circuit, 1998)
Watkins v. Telsmith, Inc.
121 F.3d 984 (Fifth Circuit, 1997)

Cite This Page — Counsel Stack

Bluebook (online)
946 F. Supp. 1241, 46 Fed. R. Serv. 125, 1996 U.S. Dist. LEXIS 18163, 1996 WL 700785, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tassin-v-sears-roebuck-and-co-lamd-1996.